Aurinia Pharmaceuticals Inc (AUPH)

[biotech_researcher]

Someone else agrees with my synopsis:


“$AUPH Dry eye trials are hard, but Aurinia should have let eye experts run the trials from the get-go. P2 trial mishap (testing for ocular discomfort within a minute of distillation instead of 24 hrs) was a sign of things to come. Lost a pound to save a penny. VOS had potential.”